Indomethacin for Acute Gout Pain
While indomethacin is FDA-approved for acute gout, current evidence shows it offers no superiority over other NSAIDs and corticosteroids should be considered first-line therapy due to better safety profiles and equal efficacy. 1
Recommended Dosing Regimen (If Indomethacin is Selected)
Standard FDA-approved dosing: Indomethacin 50 mg three times daily until pain is tolerable, then rapidly reduce to complete cessation. 2
- Onset of action: Definite pain relief typically occurs within 2-4 hours 2
- Expected timeline: Tenderness and heat usually subside in 24-36 hours; swelling gradually disappears in 3-5 days 2
- Duration: Continue until acute attack completely resolves, typically 7-14 days 1, 2
- Maximum daily dose: Do not exceed 200 mg per day 2
Critical Context: Indomethacin Is Not Superior to Other Options
Moderate-quality evidence demonstrates no difference between indomethacin and other NSAIDs for acute gout treatment. 1 Despite being traditionally considered "first-line" among NSAIDs, there is no evidence that indomethacin is more efficacious than naproxen, ibuprofen, or other NSAIDs. 1
Comparative Efficacy Data:
- Etoricoxib 120 mg once daily showed comparable efficacy to indomethacin 50 mg three times daily with significantly fewer drug-related adverse events (16.5% vs 37.2%, P<0.05) 3
- Ketoprofen 100 mg three times daily demonstrated equivalent efficacy and safety to indomethacin 4
- Corticosteroids (prednisolone 35 mg for 5 days) are as effective as NSAIDs with fewer adverse effects 1
Preferred Treatment Algorithm
The American College of Physicians (2017) recommends the following hierarchy: 1
First-line: Corticosteroids (prednisolone 35 mg daily for 5 days) - generally safer with fewer adverse effects than NSAIDs 1
Alternative first-line options:
Continue treatment at full dose until the acute attack completely resolves 1
Contraindications and Precautions
NSAIDs including indomethacin are contraindicated in patients with: 1
- Renal disease (chronic kidney disease)
- Heart failure
- Cirrhosis
- History of gastrointestinal bleeding or peptic ulcer disease
Common adverse effects of indomethacin: 1
- Dyspepsia
- Gastrointestinal perforations, ulcers, and bleeding
- Headaches (reported in 15/40 patients in one study) 5
- Difficulty with mentation (reported in 12/40 patients) 5
- Abdominal discomfort (reported in 22/40 patients) 5
Common Pitfalls to Avoid
Do not use indomethacin reflexively as "the gout drug" - this is tradition-based practice not supported by evidence. 1 The 2017 ACP guidelines explicitly state that although indomethacin is commonly considered first-line, there is no evidence for its superiority. 1
Do not continue NSAIDs longer than necessary - use the shortest duration consistent with symptom resolution to minimize adverse events. 2
Do not use high-dose colchicine regimens - the older regimen (1.2 mg followed by 0.6 mg every hour for 6 hours) causes severe gastrointestinal toxicity without additional efficacy benefit compared to low-dose regimens. 1
Consider patient-specific factors:
- Elderly patients have increased risk of adverse reactions with NSAIDs 2
- Patients on anticoagulation have higher bleeding risk
- Those with cardiovascular disease may be better served by corticosteroids 1, 6
Alternative Approaches with Better Safety Profiles
Systemic corticosteroids: Prednisone 0.5 mg/kg per day for 5-10 days at full dose then stop, OR for 2-5 days at full dose then taper for 7-10 days 1
Intramuscular corticosteroids: Triamcinolone acetonide 60 mg IM provided faster pain relief (mean 3±1 hours) compared to indomethacin (24±10 hours) with no side effects versus multiple adverse events with indomethacin 5
COX-2 selective inhibitors (where available outside the US): Etoricoxib demonstrated comparable efficacy with better tolerability than indomethacin 1, 3